Research and Markets: 2015-2019 US Respiratory Disease Testing Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis Sales Segment Forecasts

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/qsl945/20152019_us) has announced the addition of the "2015-2019 US Respiratory Disease Testing Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis-Competitive Strategies, Supplier Shares by Test, Country Volume and Sales Segment Forecasts" report to their offering.

'2015-2019 US Respiratory Disease Testing Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Emerging Opportunities for Instrument and Reagent Suppliers - Competitive Strategies, Supplier Shares by Test, Country Volume and Sales Segment Forecasts'.

This new 282-page report provides analysis of the US respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

This report presents detailed analysis of the Respiratory Disease market in the US. Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

The report provides test volume and sales forecasts and market segment, including:

- Hospitals

- Commercial/Private Labs

- Physician Offices

- Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of respiratory disease diagnostic products, by test.

Also, the report:

- Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; thirteen

- Reviews features and operating characteristics of major analyzers used for respiratory disease testing;

- Profiles key suppliers and potential market entrants developing innovative technologies and products; and

- Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

For more information visit http://www.researchandmarkets.com/research/qsl945/20152019_us

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In Vitro Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In Vitro Diagnostics